Kronenberg, Florian

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

Langlois, M. R., Nordestgaard, B. G., Langsted, A., Chapman, M. J., Aakre, K. M., Baum, H., Borén, J., Bruckert, E., Catapano, A., Cobbaert, C., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM)

Lipoproteins and Cardiovascular HealthClinical Laboratory Practices and Quality Control

Cited by 211

Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis

Willeit, P., Raschenberger, J., Heydon, E. E., Tsimikas, S., Haun, M., Mayr, A., Weger, S., Witztum, J. L., Butterworth, A. S., Willeit, J., et al. (2014) · PLoS ONE

Telomeres, Telomerase, and SenescenceGenetic Associations and Epidemiology

Cited by 211

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

Hegele, R. A., Borén, J., Ginsberg, H. N., Arca, M., Averna, M., Binder, C. J., Calabresi, L., Chapman, M. J., Cuchel, M., von Eckardstein, A., et al. (2020) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 204

mtDNA-Server: next-generation sequencing data analysis of human mitochondrial DNA in the cloud

Weissensteiner, H., Forer, L., Fuchsberger, C., Schöpf, B., Kloss-Brandstätter, A., Specht, G., Kronenberg, F., & Schönherr, S. (2016) · Nucleic Acids Research

Genomics and Phylogenetic StudiesMitochondrial Function and Pathology

Cited by 188

A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction

Coassin, S., Erhart, G., Weissensteiner, H., Eca Guimarães de Araújo, M., Lamina, C., Schönherr, S., Forer, L., Haun, M., Losso, J. L., Köttgen, A., et al. (2017) · European Heart Journal

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 93

Dyslipidemia and nephrotic syndrome: recent advances.

Kronenberg, F. (2005) · Journal of Renal Nutrition

Lipid metabolism and disordersRenal Diseases and Glomerulopathies

Cited by 85

Association of relative telomere length with progression of chronic kidney disease in two cohorts: effect modification by smoking and diabetes

Raschenberger, J., Kollerits, B., Ritchie, J., Lane, B., Kalra, P. A., Ritz, E., & Kronenberg, F. (2015) · Scientific Reports

Chronic Kidney Disease and DiabetesTelomeres, Telomerase, and Senescence

Cited by 66

Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study

Huth, C., von Toerne, C., Schederecker, F., de las Heras Gala, T., Herder, C., Kronenberg, F., Meisinger, C., Rathmann, W., Koenig, W., Waldenberger, M., et al. (2019) · European Journal of Epidemiology

Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 56

Genome-wide studies reveal factors associated with circulating uromodulin and its relationships to complex diseases

Li, Y., Cheng, Y., Consolato, F., Schiano, G., Chong, M. R., Pietzner, M., Nguyen, N. Q. H., Scherer, N., Biggs, M. L., Kleber, M. E., et al. (2022) · JCI Insight

Genetic Associations and EpidemiologyRenal Diseases and Glomerulopathies

Cited by 22

Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in White populations

Kheirkhah, A., Schachtl-Riess, J. F., Lamina, C., Di Maio, S., Koller, A., Schönherr, S., Coassin, S., Forer, L., Sekula, P., Gieger, C., et al. (2023) · Atherosclerosis

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 10